The company from Technopolis Moscow SEZ has produced about 5.5 million units of medicinal products

More than 40 thousand cancer patients across the country received assistance in 2025 thanks to OncoTarget, a resident of the Technopolis Moscow SEZ. This was announced by Gennady Degtev, General Director of the Technopolis Moscow SEZ.

"In the SEZ "Technopolis Moscow is forming the largest pharmaceutical cluster in the country, where today there are 14 companies. They produce innovative medicines for patients in the capital and throughout Russia. Thus, a SEZ resident specializing in the production of cancer drugs produced about 5.5 million tablets in 2025," Gennady Degtev said.

OncoTarget, with the help of resident status, enjoys benefits for the development of pharmaceutical production and its own R&D center, where innovative medicines are being developed.